Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy.
Chen HW, Kuo YW, Chen CY, Chang CH, Wang SM, Chien YC, Lu WC, Chen JP, Chang CY, Wei YF, Chang SC, Shu CC, Wang JY, Liao WY, Wang HC, Yu CJ.
Chen HW, et al. Among authors: kuo yw.
Oncologist. 2024 Apr 4;29(4):e498-e506. doi: 10.1093/oncolo/oyad340.
Oncologist. 2024.
PMID: 38227604
Free PMC article.